Archives for March 19, 2014

Bioavailability Breakthrough: Aegis’ enhancement tech works in pill form

Aegis Therapeutics claims a technology developed to improve the bioavailability of drugs delivered through the nose has a similar solubility enhancement effect in a solid dosage form.

IPO positions Recipharm as mid-tier CMO with plans to grow through takeovers

Recipharm has given investors a sneak peak at its finances ahead of its IPO next month that establishes the firm as a mid-tier CMO with plans to grow through acquisitions.

DISPATCHES FROM INTERPHEX 2014

'Podular' manufacturing to become facility norm within 5 years, say GEA and G-CON

‘Podular’ manufacturing systems will dominate facility design within five years, say G-CON and GEA who have teamed with Pfizer to create a flexible, repurposable and portable facility. 

Managing excipient supply needs risk guidance, not ‘fear’ says expert

US pharmaceutical firms ‘fear change’ and need guidance on assessing safe excipient supply to become more like their European counterparts, says a senior IPEC expert.

Kemwell adds freeze-drying tech at Bangalore biologics plant

Kemwell has added commercial-scale lyophilisation capacity at its plant in Bangalore, India citing growing demand from the sterile injectables sector.

Parexel opens Singapore clinical trial supply centre

Parexel has enlarged its clinical trial supply network with the opening of a distribution centre in Singapore and expansion of its Massachusetts facilities.